Clinical trial
IV Double and Triple Concentrated Nicardipine for Stroke and ICH
NCT00325793 · OSF Healthcare System, Other · Unknown status
Key facts
| NCT number | NCT00325793 |
|---|---|
| Title | IV Double and Triple Concentrated Nicardipine for Stroke and ICH |
| Official title | An Open-Label Prospective Study to Evaluate the Safety and Efficacy of Double or Triple Concentrated Intravenous Nicardipine for Treatment of Hypertension in Patients With Ischemic Stroke, Intracerebral Hemorrhage or Subarachnoid Hemorrhage |
| Lead sponsor | OSF Healthcare System, Other |
| Collaborators | PDL BioPharma, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Nicardipine |
| Enrollment | 50 |
| Start date | Jan 1, 2004 |
| First posted | May 15, 2006 |
| Last update posted | May 15, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: